THERANEXUS
Founded in 2013, THERANEXUS is a clinical-stage, CEA-derived biopharmaceutical company developing drug candidates for the treatment of nervous system diseases. Thanks to its knowledge of neuroglial interactions, THERANEXUS is a pioneer in the design and combination of approved substances and has a solid and diversified portfolio of assets in clinical phase. This strategy allows the […] Read more